Sergio Oddi

Associate Professor of Biochemistry

University of Teramo

Italy

Research Interests

Explore related searches

Professors in Italy Professors in Immunology Immunology professors in Italy

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Dr. Sergio Oddi is an Associate Professor of Biochemistry at the University of Teramo, Italy. His research primarily focuses on neurodegenerative diseases, particularly Alzheimer's disease, and explores pharmacological interventions involving endocannabinoid signaling. He has published extensively on topics such as fatty-acid amide hydrolase inhibition, the mobility of CB2 receptors in living cells, and innovative biosensor technologies for cholesterol determination.

Articles (15)

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2022

Year:

2021

Year:

2021

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Collaborators (6)

MARINA FAVA

Università Campus Bio-Medico

ITALY

View details

Ugo Nocentini

Associate Professor

Università degli Studi di Roma La Sapienza

ITALY

View details

Virginia Cebrián

Head of Department

Mecwins SA

SPAIN

View details

Jesmond Dalli

Professor in Molecular Pharmacology, Sir Henry Dale Fellow, Lipid Mediator Unit Director

William Harvey Research Institute

UNITED KINGDOM

View details

Enrico Dainese

Dean

University of Teramo

ITALY

View details

Mauro Maccarrone

Professor and Chair of Biochemistry

University of L'Aquila

ITALY

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Sergio Oddi

Research Interests

Explore related searches

Contact this professor

About

Articles (15)

Fatty‐acid amide hydrolase inhibition mitigates Alzheimer's disease progression in mouse models of amyloidosis

Probing Native CB2 Receptor Mobility in Plasma Membranes of Living Cells by Fluorescence Recovery After Photobleaching

The endocannabinoid anandamide activates pro‐resolving pathways in human primary macrophages by engaging both CB2 and GPR18 receptors

FAAH Inhibition Counteracts Neuroinflammation via Autophagy Recovery in AD Models

Innovative Peptide-Based Plasmonic Optical Biosensor for the Determination of Cholesterol

Combination of Hydrolysable Tannins and Zinc Oxide on Enterocyte Functionality: In Vitro Insights

Effects of Long-Term Oral Administration of N-Palmitoylethanolamine in Subjects with Mild Cognitive Impairment: Study Protocol

Aβ Chronic Exposure Promotes an Activation State of Microglia through Endocannabinoid Signalling Imbalance

Microglial Endocannabinoid Signalling in AD

Cryotolerance of equine spermatozoa correlates with specific fatty acid pattern: A pilot study

Anti-Inflammatory Effects of Fatty Acid Amide Hydrolase Inhibition in Monocytes/Macrophages from Alzheimer’s Disease Patients

Author Correction: The endocannabinoid hydrolase FAAH is an allosteric enzyme

The endocannabinoid hydrolase FAAH is an allosteric enzyme

Endocannabinoid system and adult neurogenesis: a focused review

Bioactive lipids, inflammation and chronic diseases

Collaborators (6)

MARINA FAVA

Ugo Nocentini

Virginia Cebrián

Jesmond Dalli

Enrico Dainese

Mauro Maccarrone

Make your next move.